XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Sales, net $ 33,049,533 $ 43,596,926 $ 94,818,938
Cost of sales:      
Total cost of sales 34,077,709 34,489,115 66,565,655
Gross profit (loss) (1,028,176) 9,107,811 28,253,283
Operating expenses:      
Sales and marketing 5,848,164 5,706,483 4,544,052
Research and development 673,944 581,172 525,727
General and administrative 13,555,283 14,308,365 24,036,480
Total operating expenses 20,077,391 20,596,020 29,106,259
Loss from operations (21,105,567) (11,488,209) (852,976)
Other income - TIA 5,900,985 6,223,891 3,832,747
Unrealized gain (loss) on debt and equity securities 10,806,320 (10,521,166) 2,343,359
Gain on sale of equity securities   5,574,792  
Interest and other income 1,000,428 1,446,661 9,948
Interest expense (122,500) (152,166) (170,651)
Income (loss) before income taxes (3,520,334) (8,916,197) 5,162,427
Provision (benefit) for income taxes 8,366,190 (1,905,161) 83,870
Net income (loss) (11,886,524) (7,011,036) 5,078,557
Preferred Stock dividend requirements (230,444) (231,946) (232,444)
Net income (loss) applicable to common shareholders $ (12,116,968) $ (7,242,982) $ 4,846,113
Basic earnings (loss) per share $ (0.4) $ (0.24) $ 0.15
Diluted earnings (loss) per share $ (0.4) $ (0.24) $ 0.15
Weighted average common shares outstanding:      
Basic (in shares) 29,937,159 29,937,159 32,896,348
Diluted (in shares) 29,937,159 29,937,159 32,961,945
Cost of manufactured product      
Cost of sales:      
Total cost of sales $ 31,158,190 $ 30,894,985 $ 60,628,548
Royalty expense to shareholder      
Cost of sales:      
Total cost of sales $ 2,919,519 $ 3,594,130 $ 5,937,107